Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01666106 · ClinicalTrials.gov registry record
Osteonecrosis of the Jaw (ONJ) Case Registry
A clinical trial of Osteonecrosis of the Jaw, sponsored by Amgen.
- Completed
- Registry status
- 327
- Enrollment target
- 20
- Study locations
NCT01666106 is a study of Osteonecrosis of the Jaw that has completed, run by Amgen. The registered enrollment target is 327 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT01666106, a study of Osteonecrosis of the Jaw, has completed, sponsored by Amgen.
- COMPLETED
- Registry status
- 327 participants
- Enrollment target
- 20
- Study locations
Study Summary
Osteonecrosis of the Jaw (ONJ) Case Registry
Conditions Studied
Study Locations (20)
New York
- Research Site - Buffalo
- Research Site - Buffalo
- Research Site - Mineola
California
- Research Site - Beverly Hills
- Research Site - Duarte
Connecticut
- Research Site - Farmington
- Research Site - Stratford
Nebraska
- Research Site - Omaha
- Research Site - Omaha
Colorado
- Research Site - Denver
District of Columbia
- Research Site - Washington D.C.
Florida
- Research Site - Gainesville
Georgia
- Research Site - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2012-10-01 |
| Est. Completion | 2020-12-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01666106
The ClinicalTrials.gov registry entry for NCT01666106 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 327 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteonecrosis of the Jaw appearing as the primary indexed condition, and to 0 interventions.
NCT01666106 reports 20 study locations spanning 15 distinct geographic areas - top geographies include New York, California, Connecticut.
Frequently Asked Questions
What is clinical trial NCT01666106 about?
NCT01666106 is a clinical study titled "Osteonecrosis of the Jaw (ONJ) Case Registry". Osteonecrosis of the Jaw (ONJ) Case Registry
What is the current status of trial NCT01666106?
This trial is currently completed. The enrollment target is 327 participants. The study started on 2012-10-01. Estimated completion is 2020-12-16.
What conditions does trial NCT01666106 study?
This clinical trial studies the following conditions: Osteonecrosis of the Jaw.
Who is sponsoring clinical trial NCT01666106?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01666106 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteonecrosis of the Jaw
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.